Back to Results
Yun Choi, MD
Accepting New Patients
Hematologist: Assistant Professor, Tufts University School of Medicine
Department + Services
Clinical Focus Areas
Lymphoid malignancies, including non-Hodgkin lymphoma, Hodgkin lymphoma, myeloma and lymphocytic leukemias, CAR T-cell therapy
Research Focus Areas
Seeing Patients In
Tufts Medical Center
South Building, 8th Floor
800 Washington Street
Boston, MA 02111
Phone #: 617-636-6227
Fax #: 617-636-8538
2018, Outstanding House Officer in Ambulatory Care Medicine Award, Montefiore Medical Center
2017, Thrombosis.TV, Video presentation of ASH poster
Evens AM, Danilov AV, Jagadeesh D, et al. Burkitt Lymphoma in the Modern Era: Real World Outcomes and Prognostication Across 30 US Cancer Centers [published online ahead of print, 2020 Jul 14]. Blood. 2020;blood.2020006926.
Choi Y, Diefenbach CS. Polatuzumab Vedotin: a New Target for B Cell Malignancies. Curr Hematol Malig Rep. 2020;15(2):125-129.
Choi Y, Diefenbach CS. Advances in Therapy for Relapsed or Refractory Hodgkin Lymphoma. Curr Oncol Rep. 2020;22(1):6.
Choi Y, Diefenbach CS. An evaluation of brentuximab vedotin as a treatment option for stage III/IV Hodgkin lymphoma. Expert Rev Hematol. 2019;12(10):801-808.
Kushnir M, Choi Y, Eisenberg R, et al. Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data. Lancet Haematol. 2019;6(7):e359-e365.
Murtomaki A, Uh MK, Choi YK, Kitajewski C, Borisenko V, Kitajewski J, Shawber CJ. Notch1 functions as a negative regulator of lymphatic endothelial cell differentiation in the venous endothelium. Development. 2013 Jun;140(11):2365-76.
Funahashi Y, Shawber CJ, Sharma A, Kanamaru E, Choi YK, Kitajewski J. Notch modulates VEGF action in endothelial cells by inducing Matrix Metalloprotease activity. Vascular Cell. 2011 Jan 18; 3(1): 2.